Synergy Pharmaceuticals Inc (NASDAQ:SGYP)

1.89
Delayed Data
As of Jun 19
 +0.08 / +4.42%
Today’s Change
1.43
Today|||52-Week Range
4.84
-15.25%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Pharmaceuticals: Other
MARKET CAP
$454.0M

Company Description

Synergy Pharmaceuticals, Inc. engages on the development and commercialization of novel gastrointestinal therapies. Its commercial product, plecanatide, is marketed under the trademark name TRULANCE, which seeks to treat adults with chronic idiopathic constipation and irritable bowel syndrome with constipation. The company was founded by Kunwar Shailubhai on November 15, 2005 and is headquartered in New York, NY.

Contact Information

Synergy Pharmaceuticals, Inc.
420 Lexington Avenue
New York New York 10170
P:(212) 297-0020
Investor Relations:
(212) 584-7610

Employees

Shareholders

Individual stakeholders6.89%
Mutual fund holders25.64%
Other institutional23.95%

Top Executives

Troy HamiltonChief Executive Officer & Director
Gary G. GemignaniSecretary, CFO, Principal Accounting Officer & EVP
Patrick H. GriffinChief Medical Officer & Executive Vice President
Chhaya ShahSenior VP-Manufacturing & Technical Operations
Dan DunhamChief Compliance Officer & Senior Vice President